Top Highlights for August 2013: (Please click on news title to view details)
- Smith & Nephew has $1.5 billion for acquisitions in US, India, China, Brazil and Russia
- Claris Life Sciences, India completes transfer of its infusion business; receives $161 million (Rs. 1,050 Cr)
- After acquiring L&T’s medical equipment business, India based Skanray Tech, set to raise funds worth $10.70 million (Rs.70 Cr) for overseas acquisitions
- India based Metropolis, enters Kenyan market with aSh40 million Lab, to further invest Sh490 Million in 5 years
- India based ReaMetrix acquired by Beckman Coulter LS, US for an undisclosed amount
- India,Germany to initiate joint research in Health & Biomedical Sciences under National funding programmes
- India based $1.74 bn Lupin acquires US rights to market Romark Laboratories’s anti-diarrhea drug to augment their growth and profitability
- India's Venus Remedies bags marketing rights to grab maximum share in the $270 million meropenem market in EU;aims to penetrate the market in 15 more countries by Q1 2014
- $6.x billion Mylan makes India its largest product sourcing base owing to more than 60% cost advantage and its 10000+ strong workforce in India
- Everist Genomics targets markets in India, Canada & Europe for its exponential growth
Aagami - Company Updates:
- Aagami CEO Mr. Dinesh Jain to attend BioPharm America 2013 this September in Boston, MA
Please Note: Aagami has moved to a new office!
We are pleased to announce that we have moved to a new office located at:
2135 City Gate Lane, Suite 300
Naperville IL 60563
The new development will enable the company to accommodate its clients more
effectively and efficiently.